Title : Colorectal Cancer Yields to Dual HER2 Blockade.

Pub. Date : 2016 Jul

PMID : 27165728






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 According to data from a phase II study, the anti-HER2 combination of trastuzumab and lapatinib is active in patients with KRAS-wild-type, HER2-positive metastatic colorectal cancer. Lapatinib KRAS proto-oncogene, GTPase Homo sapiens